tiprankstipranks
Vir Biotechnology Ends Influenza Deal with GlaxoSmithKline
PremiumCompany AnnouncementsVir Biotechnology Ends Influenza Deal with GlaxoSmithKline
2M ago
Vir Biotechnology reports Q4 EPS (86c), consensus ($1.01)
PremiumThe Fly
Vir Biotechnology reports Q4 EPS (86c), consensus ($1.01)
2M ago
Vir Biotechnology Announces Executive Leadership Transition
PremiumCompany Announcements
Vir Biotechnology Announces Executive Leadership Transition
2M ago
Vir Biotechnology price target lowered to $85 from $95 at H.C. Wainwright
PremiumThe FlyVir Biotechnology price target lowered to $85 from $95 at H.C. Wainwright
3M ago
Vir Biotech (NASDAQ:VIR) to Close R&D Facilities and Slash Workforce
PremiumMarket News
Vir Biotech (NASDAQ:VIR) to Close R&D Facilities and Slash Workforce
4M ago
Vir Biotechnology announces strategic imperatives, to cut 75 positions
PremiumThe Fly
Vir Biotechnology announces strategic imperatives, to cut 75 positions
4M ago
Vir Biotechnology appoints Jennifer Towne, Ph.D., as Chief Scientific Officer
PremiumThe FlyVir Biotechnology appoints Jennifer Towne, Ph.D., as Chief Scientific Officer
6M ago
Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference
PremiumPress Releases
Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference
6M ago
Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023
PremiumPress Releases
Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100